The NLRP3 inflammasome as a new target in respiratory disorders treatment
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1006654
Abstract: In recent years a continuous increase in new cases of respiratory disorders, such as rhinitis, asthma, and chronic obstructive pulmonary disease (COPD), has been observed. The exact pathomechanism of these diseases is still blurry, resulting… read more here.
Keywords: new target; treatment; inflammasome new; nlrp3 inflammasome ... See more keywords